Evidence map›Paper›PMID 31362557›Full record

Trial reportThe bone & joint journal2019

Clinical and cost implications of using immediate MRI in the management of patients with a suspected scaphoid fracture and negative radiographs results from the SMaRT trial.

T Rua, B Malhotra, S Vijayanathan, L Hunter, J Peacock, J Shearer, V Goh, P McCrone, S Gidwani

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The bone & joint journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

T RuaKing's Health Economics, King's College London, London, UK.
B MalhotraClinical Imaging and Medical Physics Directorate, Guy's and St Thomas' NHS Foundation Trust, London, UK.
S VijayanathanClinical Imaging and Medical Physics Directorate, Guy's and St Thomas' NHS Foundation Trust, London, UK.
L HunterEmergency Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
J PeacockSchool of Population Health and Environmental Sciences, King's College London, London, UK.
J ShearerKing's Health Economics, King's College London, London, UK.
V GohClinical Imaging and Medical Physics Directorate, Guy's and St Thomas' NHS Foundation Trust, London, UK.
P McCroneKing's Health Economics, King's College London, London, UK.
S GidwaniDepartment of Orthopaedics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
King's College London · GBGuy's and St Thomas' NHS Foundation Trust · GB

Funding

Cancer Research UK 16463
6 · The paper itself

Abstract

aimsThe aim of the Scaphoid Magnetic Resonance Imaging in Trauma (SMaRT) trial was to evaluate the clinical and cost implications of using immediate MRI in the acute management of patients with a suspected fracture of the scaphoid with negative radiographs. PATIENTS AND

methodsPatients who presented to the emergency department (ED) with a suspected fracture of the scaphoid and negative radiographs were randomized to a control group, who did not undergo further imaging in the ED, or an intervention group, who had an MRI of the wrist as an additional test during the initial ED attendance. Most participants were male (52% control, 61% intervention), with a mean age of 36.2 years (18 to 73) in the control group and 38.2 years (20 to 71) in the intervention group. The primary outcome was total cost impact at three months post-recruitment. Secondary outcomes included total costs at six months, the assessment of clinical findings, diagnostic accuracy, and the participants' self-reported level of satisfaction. Differences in cost were estimated using generalized linear models with gamma errors.

resultsThe mean cost up to three months post-recruitment per participant was £542.40 (sd £855.20, n = 65) for the control group and £368.40 (sd £338.60, n = 67) for the intervention group, leading to an estimated cost difference of £174 (95% confidence interval (CI) -£30 to £378; p = 0.094). The cost difference per participant increased to £266 (95% CI £3.30 to £528; p = 0.047) at six months. Overall, 6.2% of participants (4/65, control group) and 10.4% of participants (7/67, intervention group) had sustained a fracture of the scaphoid (p = 0.37). In addition, 7.7% of participants (5/65, control group) and 22.4% of participants (15/67, intervention group) had other fractures diagnosed (p = 0.019). The use of MRI was associated with higher diagnostic accuracy both in the diagnosis of a fracture of the scaphoid (100.0%

conclusionThe use of immediate MRI in the management of participants with a suspected fracture of the scaphoid and negative radiographs led to cost savings while improving the pathway's diagnostic accuracy and patient satisfaction. Cite this article:

Indexed as

Cost-Benefit AnalysisAdolescentAdultAgedCost SavingsEmergency Service, HospitalFemaleFollow-Up StudiesFractures, BoneHealth Care CostsHumansLinear ModelsMagnetic Resonance ImagingMaleMiddle AgedPatient SatisfactionCost analysisDiagnostic accuracyImmediate MRISuspected scaphoid fracture

Identifiers

PMID31362557
PMCPMC6681676
OpenAlexW2965107295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.